Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis

Bibliographic Details
Title: Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis
Authors: Ljubicic Lidija, Janzic Urska, Unk Mojca, Terglav Ana Sophie, Mohorcic Katja, Seiwerth Fran, Bitar Lela, Badovinac Sonja, Plestina Sanja, Korsic Marta, Kukulj Suzana, Samarzija Miroslav, Jakopovic Marko
Source: Radiology and Oncology, Vol 57, Iss 3, Pp 397-404 (2023)
Publisher Information: Sciendo, 2023.
Publication Year: 2023
Collection: LCC:Medical physics. Medical radiology. Nuclear medicine
Subject Terms: advanced nsclc, antiangiogenic therapy, docetaxel, nintedanib, real-world data, Medical physics. Medical radiology. Nuclear medicine, R895-920
More Details: The standard first-line systemic treatment for patients with non-oncogene addicted advanced nonsquamous non-small cell lung cancer (NSCLC) is immunotherapy with immune checkpoint inhibitors (ICI) and/or chemotherapy (ChT). Therapy after failing ICI +/− ChT remains an open question, and docetaxel plus nintedanib represent a valid second line option.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1581-3207
Relation: https://doaj.org/toc/1581-3207
DOI: 10.2478/raon-2023-0040
Access URL: https://doaj.org/article/956b32553a3347c1bdae4e7034beddb4
Accession Number: edsdoj.956b32553a3347c1bdae4e7034beddb4
Database: Directory of Open Access Journals
More Details
ISSN:15813207
DOI:10.2478/raon-2023-0040
Published in:Radiology and Oncology
Language:English